Emerging Biotech
Novogene aims to strengthen its service offerings in long-read sequencing applications with PacBio latest Revio sequencer. As an early adopter of PacBio Re...
January 10, 2024 | News
Libtayo (cemiplimab) is a leading PD-1 inhibitor that has shown efficacy in the treatment of certain patients with cutaneous squamous cell carcinoma, adv...
January 09, 2024 | News
Clarametyx Biosciences Inc. (“Clarametyx”), a clinical stage company developing targeted, immune-enabling biologic therapies to counter persist...
January 08, 2024 | News
JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immun...
January 05, 2024 | News
Company announces development of novel ionizable lipids and stabilizing components eTurna™ delivery platform expected to improve safety, redu...
January 04, 2024 | News
At the heart of this partnership lies the establishment of a cutting-edge laboratory, outfitted with state-of-the-art, high-end equipment generously provid...
January 03, 2024 | News
Heranova Lifesciences Holding Ltd. ("Heranova") announced the successful completion of a USD 13.5 million seed and seed+ financing to devel...
December 29, 2023 | News
Unveiling the Pioneering Companies Poised to Transform Healthcare 1. QuantumGen Website: quantumgen.com Location: San Francisco, CA, USA Focu...
December 29, 2023 | News
Orphan drugs, also known as drugs for rare diseases, are drugs for preventing, treating or diagnosing rare diseases. Being designated as orphan drugs will ...
December 28, 2023 | News
Nectin Therapeutics Ltd., (Nectin), a biotechnology company developing novel targeted immunotherapies that address resistance to approved immune oncology t...
December 27, 2023 | News
Through the acquisition of Propella, Astellas has acquired PRL-02 (abiraterone decanoate), a next-generation androgen biosynthesis inhibitor being develope...
December 22, 2023 | News
Singapore-headquartered Juniper Therapeutix, a science-led healthcare company focused on commercializing novel therapies, announced its agreement with...
December 22, 2023 | News
"A single center, single-arm, dose-escalation, exploratory clinical trial to examine the safety, tolerability, pharmacokinetics and prelimina...
December 21, 2023 | News
Biorithm, a global women's health medtech, has closed $3.5 million in Series A funding, co-led by Adaptive Capital Partners and SEEDS Capital. Wi...
December 19, 2023 | News
Most Read
Bio Jobs
News